InvestorsHub Logo

Lloyd Cannabinoid

01/21/19 7:59 AM

#30377 RE: Topchef #30376

pps going down to .0005 or less.

BottomTurn

01/21/19 9:28 AM

#30384 RE: Topchef #30376

I'm invested in NOUV and Kaly. We are partners with PURA also, so I truly believe the ship is not sinking as you all may say and think, and or try to make others think. USCH will succeed in being brought out by a bigger entity as they have planned, a bigger phamacitical company. Or better yet a large beverage company. Raising their extraction to 25% and the statement the CEO stated in his last PR leads me to believe this, and its happening as we speak.

Thinking outside the box…

I really like this highlighted statement. Think he’s hinting at something? Read into it,
(thought I would mention that today in light of AB announcements)

Why would he think to mention it? The way he stuck it in there, sounds like he wants to tell us something, so he thought he would mention it???

Another words PUT IT OUT THERE….
OH BOY, THE THOUGHTS GOING THROUGH MY MIND, FUNNY HOW THEY UPPED THE CBD AMOUNTS TO 25% also….hummmm

While the big players invest money to explore potential cannabis infused beverage industry production, Puration has $1 million in cannabis infused beverage sales under its belt and has set a goal on ringing $5 million in sales next year.

"By the way, we’ve already experimented with hemp beer. I thought I’d mention that today in light of the Anheuser Busch announcement.”

Puration recently released a 2018 year-end report detailing the company’s historical sales and 2019 sales goals. The report also includes new information on previously announced plans to issue a dividend of Nouveau Life Pharmaceuticals, (USOTC: NOUV) (“NOUV”) stock to PURA shareholders that will speed up the issuance in addition to, management believes, improving the overall value of the dividend. Management also includes in the update highlights of business developments with US Cannabis Health partners NOUV and Kali-Extracts (USOTC: KALY).